-->

Type something and hit enter


On

Table: ANALYSIS ON THE 3QR 2021 RESULT OF NEXGRAM (0096)

 

 

Revenue and Net Profit / (Net Loss) For The Quarter

Quarter

1QR 2021

(RM)

2QR 2021

(RM)

3QR 2021

(RM)

Remarks

Revenue

12,945,612

33,293,774

 

27,716,795

 

3QR on 2QR, revenue decreased 16.8%  mainly due to The Group’s revenue decreased 16.8% due to the

decrease in revenue contribution from subsidiary in healthcare division ( may be referred to the decrease in contribution from the manufacturing of medical plastic products by its subsidiary, Arita Plastic.

 

Year on Year, 3QR revenue increased 515.6%  mainly due to revenue contribution from the new

division (i.e. healthcare) which mainly attributable from manufacturing of medical plastic products, providing Tracvirus Covid-19 related services and distribution of Covid-19 test kits

Net Profit/(Net Loss)

(2,813,692)

1,405,641

(1,201,183)

3QR on 2QR, decreased ( incurred loss instead of profit in 2QR) mainly due to decrease in revenue contribution from

healthcare division which are manufacturing of medical plastic products. Also, the Group other healthcare segment is expanding on capacity resulted in further cost and the healthcare segment had experienced lower margin.

 

Year on Year, loss was stagnant at RM1.2 million.

Segmental Information For The Quarter

Segment   \  Quarter

1QR 2021

(RM)

2QR 2021

(RM)

3QR 2021

(RM)

Remarks

Medical  / Healthcare

Revenue

5,136,582

29,525,498

48,044,179

3QR on 2QR, revenue increased 62.7%

Profit/(Loss) Before Tax

(1,079,059)

55,828

(760,007)

3QR on 2QR, incurred loss from profit in 2QR.

The healthcare segment had experienced lower margin and decreased contribution from manufacturing of medical plastic.

ICT

Revenue

5,946,660

11,955,629

16,699,319

Qo3QR on 2QR,  revenue increased 39.7%.

Profit/(Loss) Before Tax

(449,232)

103,954

741,620

3QR on 2QR, profit increase 613%.

Logistics

Revenue

1,862,490

4,759,379

8,865,276

3QR on 2QR, revenue increased 86.2%.

Profit/(Loss) Before Tax

(345,605)

(826,319)

(812,173)

3QR on 2QR, loss slightly decreased.

Property Investment

Revenue

7,088

7,088

49,616

3QR on 2QR, revenue increased

Profit/(Loss) Before Tax

(832,188)

(811,776)

(1,305,618)

3QR on 2QR, loss increased

Assets And Liabilities Information

Quarter

1QR 2021

(RM)

2QR 2021

(RM)

3QR 2021

(RM)

Remarks

Fixed Deposit And Cash Balance

28,335,439

26,609,584

26,746,885

3QR on 2QR, the cash condition is slightly increased.

Total Current Assets

113,485,599

113,475,905

114,196,396

3QR on 2QR, the current assets per current liabilities ratio slightly decreased from 1.359 to 1.346.

Total Current Liabilities

83,861,078

83,498,791

84,849,590

Shareholder’s  Equity

108,879,189

120,486,796

121,482,625

Nexgram's shareholder equity on consolidated basis of its shares excluding treasury shares

 =  (RM121,482,625 ÷              

      2 15,119,923) x 100%

=    56.47  %   

 

Conclusion:

3QR on 2QR, shareholders equity  of its shares increased from 51.23%  in the last 2QR 2021 report to 56.47%

 

@@Remarks: GN3 risk ?? Lowered

 

Net Assets Per Share

0.0488

0.4504

4.511

3QR on 2QR, NTA slightly increased

 

 

Diagrams: FINANCIAL HIGHLIGHT OF NEXGRAM (0096)

 

 

 

Source: https://www.malaysiastock.biz/

 

NOTABLE NOTES FROM THE 3QR 2021 REPORT:

 

  1. Healthcare continues to progress well, with government project SafeTravelPass COVID-19 entry-registration, payment and management of Quarantine-Station and government services contributing positively in current financial year.
  2. COVID-19 tests partnership with government is looking at positive return in coming quarter after much capital investment in last two (2) quarters, in view of taking part of mass screening assignment engaged with government health facilities.
  3. Government project capital investment continue to weight on current quarter which is normal for concession early investment.
  4. The Group other healthcare segment is expanding on capacity resulted in further cost. The healthcare segment had experienced lower margin and recent success in contracts shall expect to contribute to bottom line in coming quarter.

 

MY PERSONAL NOTES BASED ON THE 3QR 2021 REPORT:

 

 

  1. The approved capital reduction exercise was not yet been taken into account in the 3QR 2021. Probably will be done in 4QR 2021 accounts.
  2. No specific report on the progress of the revenue from Indonesian, RAFA Agreement on the medical gloves and gown.

** DISCLAIMER: I wrote this article based on my research from information reported on the web. All information given should not be considered as an investment advice. Please do your own analysis or consult your qualified financial advisor for advice. All  information is not a buy call or a sell call in any securities transactions.

https://klse.i3investor.com/blogs/mzm511/2021-07-01-story-h1567122502-SOME_ANALYSIS_FROM_THE_3QR_2021_OF_NEXGRAM_0096.jsp

Back to Top
Back to Top